Introduction
interesting review on hyperparathyroidism by McGeown and Morrison [3] . The earlier view, put Primary hyperparathyroidism has evolved from what forward by Thomson and Collip [5] and Jaffe [6 ] , was was initially thought to be a very rare disease to a that the hormone acts directly on bone tissue to cause relatively frequent endocrine disorder. The rapid its dissolution, and that the changes in plasma electroimprovement in knowledge of this disease in the early lytes are secondary to the bone changes. In contrast, part of this century is due to the observations of a Albright and Ellsworth believed that the skeletal small number of internists and surgeons. A parathyroid changes were secondary to changes in blood chemistry, adenoma was for the first time successfully removed the latter being secondary to the phosphaturic action by Mandl in 1925 [1] . The first series of patients with of PTH and the subsequent decrease in serum phosprimary hyperparathyroidism was published in 1934 phorus [7] . Since in their opinion a low extracellular and reported on 17 patients [2] .
phosphate concentration would cause less saturated The present review is directed at some of the major body fluids this could provoke a compensatory dissoluissues of primary and secondary uraemic hyperparathy-tion of bone mineral, allowing restoration of the disroidism to see how they have evolved during the years. turbed extracellular calcium phosphate equilibrium. Most were already recognized in the 1950s and 1960s, The resulting increased serum calcium would explain at a time when Mary G. McGeown became progress-the often observed increase in urinary calcium excretion ively interested in the endocrine disorders of the para-which again would cause an undersaturation of the thyroid glands.
body fluids and thus perpetuate the vicious circle.
The first hypothesis of a direct PTH action at the bone level was subsequently strengthened by the
Incidence of hyperparathyroid diseases
demonstration that PTH was capable of inducing hypercalcaemia and bony changes in nephrectomized It has long been known that hyperparathyroidism is animals [8] . However, it proved difficult to explain the not a rare disease. Based on the clinical and biochem-various features of hyperparathyroidism, such as disical means available in the late 1950s, Mary G. turbed gastric function [9], the neuromuscular synMcGeown was able to document the occurrence of drome, and pseudogout, by an action on only one primary hyperparathyroidism in 55 cases over a time target organ. Thus, the idea arose that several different period of 4 years in the population of Northern Ireland target tissues must exist. Interestingly, this hypothesis which was then 1.3 million people [3] . She calculated could be proved only 40 years later when the from these data an annual incidence of ten cases per PTH/PTHrp receptor was cloned [10] and submillion population. Since the introduction of multi-sequently found to be expressed in numerous tissues, channel autoanalysers in the late 1960s, a dramatic in addition to kidney and bone [11] . increase in the incidence became apparent which in the United States was estimated to be approximately 270 per million population [4] . A similar incidence was Clinical presentation of primary reported at that time from Great Britain and Sweden. hyperparathyroidism different faces, namely as a 'bone disease' characterized parathyroid cell [17] . Very recently it was demonstrated that phosphate also modulates PTH secretion directly by osteitis fibrosa cystica or as a 'stone disease' characterized by recurrent nephrolithiasis. , in addition to its long known indirect effects via changes in plasma calcium and calcitriol synthesis. Morrison therefore postulated that there should be more than one hormone to explain such contrasting Whereas calcitriol regulates pre-pro-PTH gene expression at the transcriptional level, calcium and phosphate phenotypes [3] . This idea again emerged 20 years later when Broadus et al. stressed the importance of appear to act mainly at post-transcriptional steps.
Calcium and calcitriol have been shown to interact an elevated serum calcitriol in the pathogenesis of hypercalciuria and renal stone formation in primary with specific receptors in the parathyroid cell membrane and nucleus, respectively. In contrast, it remains hyperparathyroidism [12] . In keeping with this, hyperparathyroid patients with predominant bone disease unclear at present by which transmembranous signalling system phosphate exerts its direct action on the had lower calcitriol, but higher PTH levels [13] . However, the occurrence of these two syndromes is parathyroid cell.
The relation between plasma Ca2+ and plasma PTH not mutually exclusive, and the distinction probably cannot be made on the sole basis of differences in exhibits an inverse sigmoidal relationship, with Ca2+ being normally regulated at a set-point which correplasma calcitriol and PTH values [14] .
The potential role of calcitonin in the clinical expres-sponds to the midpoint of the inverse sigmoidal Ca2+/PTH curve [21] . sion of primary and secondary hyperparathyroidism has been a subject of debate for years. The increase of PTH is not only secreted from the glands in a basal, tonic mode but is also released in a pulsatile fashion, plasma calcitonin in uraemic patients, which was often observed in the presence of hypocalcaemia and there-in the form of episodic secretory bursts [22, 23] .
Hypocalcaemia selectively increases pulsatile PTH fore tentatively attributed to the concomitant hyperphosphataemia, could lead to a relative protection release by stimulating both burst frequency and burst mass by a Ca-rate sensitive mechanism [24] . Oral against the bone-resorbing activity of PTH, by enhancing bone formation. It could even be responsible of calcitriol, but not i.v. calcitriol, suppresses baseline pulsatile PTH release and in addition reduces the the patchy osteosclerosis often present in such patients [15] .
pulsatile secretory capacity in response to hypocalcaemia [24] .
Diagnosis of parathyroid overfunction Pathophysiology of PTH hypersecretion and parathyroid hyperplasia
The diagnosis of hyperparathyroidism of mild to moderate degree has long been hampered by the absence of a reliable method for the determination of plasma In primary hyperparathyroidism excessive PTH secretion is associated with parathyroid tissue hyperplasia. PTH, as regretfully stated by McGeown in 1965 [16 ] . Therefore, at that time clinicians had to rely mainly Parathyroid adenomas are characterized by a monoclonal growth pattern in all cases [25] whereas in the on the measurement of secondary parameters such as plasma and urinary calcium and phosphorus, in the majority of cases of primary non-familial parathyroid hyperplasia the growth pattern is polyclonal [26 ] . absence of pathognomonic skeletal changes. The subsequent introduction of radioimmunoassays using anti-Various somatic gene mutations probably underly the transformation of normal parathyroid tissue into an bodies directed against the C-terminal, N-terminal or midregion moiety of PTH was an important step adenoma, including clonal rearrangement and overexpression of the cyclin D1/PRAD1 oncogene, allelic forward in diagnostic terms. This was particularly true for estimating the degree of secondary hyperparathy-losses on chromosome arms 1p [27] and 11q [28] , and several, recently discovered deletions in chromosome roidism in patients with chronic renal failure. However, the diagnosis of primary adenoma and hyperplasia regions 6q and 15q [29] . Mutations of the menin gene located on the 11q13 region are characteristic for remained difficult. At the end of the 1980s, the development of a double sandwich radioimmunoassay, patients with the multiple endocrine neoplasia type I (MEN-I ) syndrome [30] , and germline point mutations allowing measurement of human intact PTH reliably, solved this difficulty at last. It probably has led since, of the ret proto-oncogene are involved in the tumorigenesis of MEN-2A [31] . Finally, an inactivation of the on the one hand, to the avoidance of unnecessary surgery in most instances but on the other hand it has RB tumour suppressor gene on 13q14 is common in parathyroid carcinoma, but not in primary adenoma greatly helped to indicate parathyroidectomy in patients with hyperparathyroidism of moderate degree [32] .
Concerning the pathogenesis of secondary uraemic at earlier time points than was the case previously.
hyperparathyroidism, a number of systemic and local factors are probably involved. Thus the decrease of
Factors involved in the control of PTH secretion
plasma calcium and calcitriol in early renal failure and the increase of plasma phosphate in advanced renal failure lead to a constant stimulation of PTH synthesis It is well established that PTH secretion is directly regulated by calcium and calcitriol at the level of the and/or secretion. In addition, the frequently diminished sensing receptor [34, 35] 
